Literature DB >> 26799447

Kinetic modeling and long-term test-retest reproducibility of the mGluR5 PET tracer 18F-FPEB in human brain.

Gil Leurquin-Sterk1, Andrey Postnov1, Bart de Laat1,2, Cindy Casteels1,2, Sofie Celen3, Cleo L Crunelle4, Guy Bormans3, Michel Koole1,2, Koen Van Laere1,2.   

Abstract

(18)F-FPEB is a promising PET tracer for studying the metabotropic glutamate subtype 5 receptor (mGluR5) expression in neuropsychiatric disorders. To assess the potential of (18)F-FPEB for longitudinal mGluR5 evaluation in patient studies, we evaluated the long-term test-retest reproducibility using various kinetic models in the human brain. Nine healthy volunteers underwent consecutive scans separated by a 6-month period. Dynamic PET was combined with arterial sampling and radiometabolite analysis. Total distribution volume (V(T)) and nondisplaceable binding potential (BP(ND)) were derived from a two-tissue compartment model without constraints (2TCM) and with constraining the K(1)/k(2) ratio to the value of either cerebellum (2TCM-CBL) or pons (2TCM-PONS). The effect of fitting different functions to the tracer parent fractions and reducing scan duration were assessed. Regional absolute test-retest variability (aTRV), coefficient of repeatability (CR) and intraclass correlation coefficient (ICC) were computed. The 2TCM-CBL showed best fits. The mean 6-month aTRV of V(T) ranged from 8 to 13% (CR < 25%) with ICC > 0.6 for all kinetic models. BPND from 2TCM-CBL with a sigmoid fit for the parent fractions showed the best reproducibility, with aTRV ≤ 7% (CR < 16%) and ICC > 0.9 in most regions. Reducing the scan duration from 90 to 60 min did not affect reproducibility. These results demonstrate for the first time that (18)F-FPEB brain PET has good long-term reproducibility, therefore validating its use to monitor mGluR5 expression in longitudinal clinical studies. We suggest a 2TCM-CBL with fitting a sigmoid function to the parent fractions to be optimal for this tracer.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  18F-FPEB; kinetic modelling; mGluR5; positron emission tomography; test-retest reproducibility

Mesh:

Substances:

Year:  2016        PMID: 26799447     DOI: 10.1002/syn.21890

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  7 in total

1.  In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [11C]ABP688 and [18F]FPEB.

Authors:  Christine DeLorenzo; Jean-Dominique Gallezot; John Gardus; Jie Yang; Beata Planeta; Nabeel Nabulsi; R Todd Ogden; David C Labaree; Yiyun H Huang; J John Mann; Fabrizio Gasparini; Xin Lin; Jonathan A Javitch; Ramin V Parsey; Richard E Carson; Irina Esterlis
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5.

Authors:  Geoffrey Warnock; Michael Sommerauer; Linjing Mu; Gloria Pla Gonzalez; Susanne Geistlich; Valerie Treyer; Roger Schibli; Alfred Buck; Stefanie D Krämer; Simon M Ametamey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-27       Impact factor: 9.236

Review 3.  News and views on in-vivo imaging of neurotransmission using PET and MRI.

Authors:  Christin Y Sander; Swen Hesse
Journal:  Q J Nucl Med Mol Imaging       Date:  2017-07-27       Impact factor: 2.346

4.  Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients.

Authors:  Jenny Ceccarini; Gil Leurquin-Sterk; Cleo Lina Crunelle; Bart de Laat; Guy Bormans; Hendrik Peuskens; Koen Van Laere
Journal:  J Nucl Med       Date:  2019-09-03       Impact factor: 10.057

5.  Kinetics and 28-day test-retest repeatability and reproducibility of [11C]UCB-J PET brain imaging.

Authors:  Hayel Tuncel; Ronald Boellaard; Emma M Coomans; Erik Fj de Vries; Andor Wjm Glaudemans; Paula Kopschina Feltes; David V García; Sander Cj Verfaillie; Emma E Wolters; Steven P Sweeney; J Michael Ryan; Magnus Ivarsson; Berkley A Lynch; Patrick Schober; Philip Scheltens; Robert C Schuit; Albert D Windhorst; Peter P De Deyn; Bart Nm van Berckel; Sandeep Sv Golla
Journal:  J Cereb Blood Flow Metab       Date:  2020-10-08       Impact factor: 6.200

Review 6.  Metabotropic Glutamate Receptor Subtype 5 in Alcohol-Induced Negative Affect.

Authors:  Chelsea R Kasten; Eleanor B Holmgren; Tiffany A Wills
Journal:  Brain Sci       Date:  2019-07-30

7.  Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome.

Authors:  James R Brašić; Ayon Nandi; David S Russell; Danna Jennings; Olivier Barret; Anil Mathur; Keith Slifer; Thomas Sedlak; Samuel D Martin; Zabecca Brinson; Pankhuri Vyas; John P Seibyl; Elizabeth M Berry-Kravis; Dean F Wong; Dejan B Budimirovic
Journal:  Brain Sci       Date:  2020-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.